Table 2.
ACE activity U/L |
Patients with MS (Group I) |
Control (group II) (n = 20) |
Control group MS (group III) (n = 25) |
||
---|---|---|---|---|---|
At baseline (n = 23) |
After 1 M (n = 23) |
After 2 M (n = 23) |
|||
mean ± SD | 87.0 ± 42.1P<0.001 | 64.6 ± 25.4P<0.001/∗∗∗ | 61.0 ± 34.1P=0.001/∗∗∗ | 31.3 ± 11.6 | 36.6 ± 16.53NS |
MIN–MAX | 20.3–165.5 | 29.9–135.5 | 11.0–147.0 | 8.8–60.9 | 10.31–73.0 |
***P < 0.001 versus baseline; P = values versus control healthy group (group II); NS-not statistically significant.